Bug Squad 101 and Other Antibiotic Pearls - PowerPoint PPT Presentation

1 / 21
About This Presentation
Title:

Bug Squad 101 and Other Antibiotic Pearls

Description:

De-escalation. Reduces selection pressure responsible for antimicrobial resistance by decreasing antimicrobial exposure. Contains costs . Reduces the risk of adverse ... – PowerPoint PPT presentation

Number of Views:140
Avg rating:3.0/5.0
Slides: 22
Provided by: nursesaste
Category:

less

Transcript and Presenter's Notes

Title: Bug Squad 101 and Other Antibiotic Pearls


1
Bug Squad 101 and Other Antibiotic Pearls
  • Chelsea Mannebach
  • September 21st, 2011

2
Objectives
  • Explain the purpose and goals of Bug Squad
  • Discuss the importance of appropriate
    antimicrobial utilization
  • Describe clinical pearls relating to antibiotic
    administration

3
Audience Poll
  • What do you know about Bug Squad?
  • (Have you ever heard about Bug Squad?)

4
Bug Squad
  • Multidisciplinary team
  • Microbiology
  • Infection prevention
  • Medicine
  • Pharmacy
  • Twice weekly meetings
  • Goal
  • Antimicrobial stewardship/appropriate
    antimicrobial utilization

5
Audience Poll
  • Why target antimicrobials?

6
Issues
  • 10-30 of the average hospital pharmacy budget is
    spent on antimicrobials
  • Up to 50 of antibiotic use in hospitals is
    estimated to be inappropriate
  • Increasing rate of bacterial resistance thought
    to be in part due to antibiotic use
  • Improvements in antimicrobial use has been shown
    to improve patient outcomes and reduce resistance
    rates
  • Decreased number of antimicrobial drugs in
    pipeline

From Antimicrobial Stewardship, Jamie Winner.
Management of Infectious Diseases 32nd Annual
Madison Clinical Conference. March 30, 2011.
7
Audience Poll
  • What is antimicrobial stewardship?

8
Antimicrobial Stewardship Goals
  • Optimize patient outcomes through improved
    antimicrobial utilization
  • Efficacy
  • Toxicity
  • Resistance
  • Reduce health care costs without adversely
    impacting quality of care
  • Length of stay
  • Drug cost

From Antimicrobial Stewardship, Jamie Winner.
Management of Infectious Diseases 32nd Annual
Madison Clinical Conference. March 30, 2011.
9
Microbiology
  • Culture information
  • Latest reports help guide de-escalation and
    appropriate antibiotic selection
  • Insight
  • Resistance Data
  • Antibiogram
  • Problem Bugs
  • MRSA (Methicillin Resistant Staphylococcus
    Aureus)
  • ESBLs (Extended Spectrum Beta Lactamases)
  • VRE (Vancomycin Resistant Enterococci)
  • KPCs (Klebsiella Pneumoniae Carbapenemases)
  • C. difficile

10
Audience Poll
  • Why de-escalate?

11
De-escalation
  • Reduces selection pressure responsible for
    antimicrobial resistance by decreasing
    antimicrobial exposure
  • Contains costs
  • Reduces the risk of adverse events

From Antimicrobial Stewardship, Jamie Winner.
Management of Infectious Diseases 32nd Annual
Madison Clinical Conference. March 30, 2011.
12
Antibiogram
  • Susceptibility rates
  • Minimum Inhibitory Concentration (MIC)
    breakpoints
  • Dosing information
  • Cost data

13
Infection Prevention
  • VAP
  • Ventilator-associated pneumonia
  • CAUTI
  • Catheter-associated UTI
  • CLABSI
  • Central line-associated blood stream infection
  • Isolation requirements
  • MRSA
  • c. difficile
  • ESBLs
  • Viruses (roto, RSV, influenza)
  • Meningitis (neisseria)
  • Sepsis Campaign
  • Protocols
  • Criteria
  • Mortality rate
  • Public Health

14
Medicine
  • Dr. Gray
  • pathology
  • Dr. Skeem
  • internists
  • Dr. Workman
  • surgery

15
Pharmacy
  • Selection and streamlining
  • Dose optimization
  • Patient characteristics
  • renal function, age, weight
  • Site of infection
  • meningitis, neutropenic fever, pneumonia
  • Pharmacokinetics
  • monitoring levels
  • IV to PO Conversion

From Antimicrobial Stewardship, Jamie Winner.
Management of Infectious Diseases 32nd Annual
Madison Clinical Conference. March 30, 2011.
16
Outcome Measurements
  • Microbiologic
  • Susceptibilities and resistance
  • Number of infections due to specific organisms
  • Clinical
  • Adverse drug events
  • Mortality
  • Clinical cure
  • Length of stay
  • Readmission rates
  • Financial
  • Cost savings

From Antimicrobial Stewardship, Jamie Winner.
Management of Infectious Diseases 32nd Annual
Madison Clinical Conference. March 30, 2011.
17
Antibiotic Clinical Pearls
  • Sepsis
  • Source control
  • Timeliness
  • Pharmacokinetics
  • Therapeutic window
  • Monitoring levels
  • Time dependent vs. concentration dependent

18
Sepsis
  • 50-70 mortality
  • Mortality increases 7-10 every hour if not
    treated with goal-directed care
  • Sepsis Campaign (started 2002)
  • Reduce mortality to 25
  • Goal-directed therapy
  • Reperfusion
  • Labs and cultures
  • Source control
  • Antibiotics

Surviving sepsis campaign international
guidelines for management of severe sepsis and
septic shock 2008. 2004 (revised 2008 Jan).
NGC006316. Society of Critical Care Medicine
19
Pharmacokinetics
  • Concentration-dependent Antibiotics
  • Fluoroquinolones
  • Aminoglycosides
  • Time-dependent Antibiotics
  • Vancomycin
  • B-lactams

20
Summary
  • Dry pipeline, we are stuck with what we have
  • Bugs are smart
  • Essential that we protect our patients and our
    antimicrobials
  • Nursing plays an important role in ensuring
    appropriate and timely antimicrobial
    administration

21
Questions?
Write a Comment
User Comments (0)
About PowerShow.com